Blog - Page 2989 of 5695

WednesdayJul 17, 2013 9:03 am

GRILLiT, Inc. (GRLT) Signs LOI to Add Third Restaurant

Today before the opening bell, GRILLiT announced the execution of a letter of intent ("LOI") to acquire an existing restaurant. After a low-cost retrofit, the location would serve as the company’s third location in South Florida. Located in a well-trafficked area next to the University of Miami, the restaurant is expected to be in GRILLiT’s possession no later than August 27, 2013. GRILLiT has already paid the initial deposit into escrow as required by the terms of the LOI. GRILLiT CEO, Raymond Dias, stated, "We are extremely pleased to have the opportunity for this store location. It is a perfect…

TuesdayJul 16, 2013 4:12 pm

Players Network (PNTV) Uses Proprietary Cloud-Based Platform to Deliver Integrated Marketing Solution

Players Network is a media and entertainment company using its proprietary cloud-based technology to create and distribute gaming lifestyle media programming through various media platforms such as video on demand, Internet, satellite television, packaged media, and through its own Web site. The company’s "Vegas On Demand" lifestyle channel is currently available in more than 27 million homes over Comcast, DirecTV, AT&T, Verizon, Dish Network, its own broadband network, Hulu, Blinkx, Google, YouTube, and Yahoo Video, as well as on DVD, mobile platforms, and through worldwide television syndication. Based in Las Vegas, Players Network has established a line of digital lifestyle…

TuesdayJul 16, 2013 2:29 pm

Rafarma Pharmaceuticals, Inc. (RAFA) Announces New Exclusive Production Contract to Produce Anti-Cancer Drug Imatinib

Rafarma Pharmaceuticals, producer of generic antibiotics and specialty pharmaceuticals in addition to its own line of proprietary products, today reported the signing of a new exclusive production agreement with JSC F-Synthesis for the production of the anti-cancer drug Imatinib. According to Pharmexpert, the leader in the Russian market for pharmaceutical business analysis, the market for Imatinib in Russia last year totaled slightly less than $200 million (USD). JSC F-Synthesis alone sold $30 million (USD) worth of Imatinib in 2012, putting the company in the top three national vendors of Imatinib. In today’s press release, Rafarma told investors that this new…

TuesdayJul 16, 2013 12:26 pm

Cardium Therapeutics, Inc. (CXM) Channels Resources to Fulfill Strategic Business, Growth Strategy

Cardium Therapeutics focuses on the fields of health sciences and regenerative medicine to carry out its business model of acquiring and developing new and innovative bio-medical product opportunities and businesses with the potential to address significant unmet medical needs. Prospective acquisition targets are selected based on their potential pathways to commercialization, partnering, and other economic monetizations. The company’s medical opportunities portfolio is currently comprised of the Tissue Repair Company, Cardium Biologics, and the newly acquired To Go Brands healthy nutraceutical supplement business. Cardium’s lead commercial product, Excellagen® topical gel for wound care management, has received FDA clearance for marketing and…

TuesdayJul 16, 2013 12:04 pm

Timely VentriPoint Diagnostics Ltd. (VPTDF) Heart Analysis System Positioned for Pulmonary Arterial Hypertension Application

VentriPoint’s Angelo (VMS™) heart analysis system provides a quick and accurate assessment of the right ventricle heart function. Following several installation in multiple sites in cardiac centers in Europe, Canada, and the United States, the company aims to install the device in more centers and expand its applications beyond congenital heart disease in adults and children. Angelo’s (VMS™) 2D ultrasound imaging provides the accuracy of an MRI but eliminates several disadvantages of traditional imaging, such as a long procedure time, a claustrophobic environment, general anesthesia often needed for children, lengthy heart analysis process, and the need for a second trip…

TuesdayJul 16, 2013 9:27 am

Mabwe Minerals, Inc. (MBMI) Achieves Key Milestone, Begins Mining Operations at Dodge Mine

Mabwe Minerals, a U.S.-based minerals company with operations through affiliates in Zimbabwe, has commenced barite and limestone production at Dodge Mine after receiving the appropriate certification and permits from The Environmental Management Agency (EMA). The company says that obtaining the EIA permit validates its presence as a viable foreign investment company in the mining sector. Mabwe Minerals' mining and construction partner, WGB Kinsey & Company, is now on site building long-term infrastructure and shaping the open pit. Mabwe Minerals anticipates beginning barite and limestone production this month. Barite revenue is expected this quarter as Mabwe Minerals begins staging qualification lots…

TuesdayJul 16, 2013 9:19 am

The Aristocrat Group Corp. (ASCC) Positioned Well for Upcoming Product Launch

Today in a press release, the Aristocrat Group highlighted its advantageous position and how well the company is poised for a lucrative fourth quarter. With two upcoming brand launches and vodka consumption in the United States continuing to rise, management is extremely confident in its ability to rapidly grow in the thriving $5.5 billion U.S. vodka market. ASCC’s brand management division, Luxuria Brands, plans to launch two vodkas in the very near future. The first product will be RWB Ultra-Premium Handcrafted Vodka, a distinct vodka the federal government has approved labeling to be marketed as gluten-free. Soon after the release…

MondayJul 15, 2013 4:30 pm

Solar Wind Energy Tower, Inc. (SWET) Obtains $3 Million Equity Facility Agreement Commitment

Solar Wind Energy Tower, the inventor of a large Solar Wind Downdraft Tower structure capable of producing abundant, inexpensive electricity, just announced that it has received a commitment from Beaufort Ventures, PLC to fund up to $3,000,000 over a period of up to 36 months under the terms of an Equity Facility Agreement. Ronald Pickett, CEO, commented, "Solar Wind Energy is rapidly approaching a turning point where all of the valuable research and intellectual property advancements will be deployed in direct pursuit of its first Solar Wind Energy Tower project. We are pleased to have obtained this $3,000,000 commitment, which…

MondayJul 15, 2013 4:10 pm

VistaGen Therapeutics, Inc. (VSTA) Continues to Grow Key Partnerships

VistaGen, developers of a unique stem-cell based bioassay platform for use in the early identification and elimination of toxicity issues during drug development, plans to use their technology to create a valuable pipeline of drug rescue variants. The company is targeting new drugs that have shown significant potential, but which have been shelved due to heart or liver toxicity issues. VistaGen can effectively rescue those drugs, using their proprietary bioassay technology to help economically solve the toxicity problems, thereby benefitting from all of the research that went into developing the drugs in the first place. The profit potential is enormous,…

MondayJul 15, 2013 2:32 pm

International Stem Cell Corp. (ISCO) Not Limited to a Particular Stem Cell Application

Every living thing owes its existence to cells, with the average adult human body made up of nearly 100 trillion of them. So it’s not surprising that cellular processes are at the heart of human disease. And, since stem cells are the ultimate source cells from which specialized cells are generated, stem cell technology is seen as a powerful tool for overcoming a wide range of diseases. So many new discoveries and applications are now being experienced that the overall stem cell market is seen by some as being virtually boundless. The advantage of International Stem Cell Corporation is that…

Site Search

Company Search